WAVEMAN · COMPANY

IART · Integra Lifesciences Holdings Corp

LIVE

TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475

← ALL COMPANIES

IART

Name: INTEGRA LIFESCIENCES HOLDINGS CORP (IART) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

INTEGRA LIFESCIENCES HOLDINGS CORP

MEDICAL DEVICES · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · CIK 0000917520

SEC FILINGS☆ WATCH

INSIDER NET · 180D

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

117

13F, latest reported quarter

REVENUE GROWTH

+1.5%

XBRL, annual

NET MARGIN

-31.6%

CONVERSIONS · 180D

codes C/M, not in net · $0 priced

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

no Form 4 purchases or sales on file

CONGRESS

no member of Congress has reported trading it

FUNDS

117 funds added or opened last quarter

more than 61% of Medical Devices

REVENUE

+1.5% year over year

below 70% of Medical Devices

MARGIN

-31.6% net margin

below 66% of Medical Devices

BUYBACKS

$221.0K repurchased, FY to 2025-12-31

below 93% of Medical Devices

SHORT

8.3% of shares outstanding short · 5.8 days to cover · settled 2026-07-31

more than 82% of Medical Devices

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

117 funds added or opened positions in the latest 13F quarter, of 213 holders.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN +8.4%

+8.4%12M

INSIDER BUY

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

The complete filing record, in one place.

The record shows 117 funds added last quarter. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

TMO PEN ROK BLFS MTD SIBN WRBY ISRG TXG DXCM EW TMDX

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

No insider purchases or sales are on record for INTEGRA LIFESCIENCES HOLDINGS CORP in the period covered. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER

FILED

VALUE

GRAVES JEFFREY A

Director

BUY

2025-11-05

9,000.0

$102.2K

Schwartz Eric

EVP, Chief Legal Officer & Sec

SELL

2024-12-03

4,070.0

$100.1K

McBreen Michael J.

EVP & President, CSS

SELL

2024-12-02

1,700.0

$41.1K

Mosebrook Jeffrey

SVP, Fin & Princ Acct Officer

SELL

2024-08-19

1,191.0

$25.7K

ESSIG STUART

Exec. Chairman of the Board

BUY

2024-05-23

52,641.0

$1.5M

32 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 27 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

BlackRock, Inc.

10,684,103.0 sh

$191.9M

Rubric Capital Management LP

7,753,934.0 sh

$139.3M

Invesco Ltd.

3,749,367.0 sh

$67.3M

VANGUARD PORTFOLIO MANAGEMENT LLC

3,743,093.0 sh

$67.2M

MORGAN STANLEY

3,593,079.0 sh

$64.5M

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

Paradigm Micro-Cap Fund

$4.7M POSITION · AS OF 2026-03-31

3.5%

Paradigm Value Fund

$942.0K POSITION · AS OF 2026-03-31

2.1%

ROBO Global Healthcare Technology and Innovation ETF

$765.1K POSITION · AS OF 2026-04-30

1.4%

State Street(R) SPDR(R) S&P(R) Health Care Equipment ETF

$1.7M POSITION · AS OF 2026-03-31

1.3%

HARTFORD SMALL CAP VALUE FUND

$3.0M POSITION · AS OF 2026-04-30

1.1%

Small Cap Equity Portfolio

$9.4M POSITION · AS OF 2026-04-30

1.0%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12	2023-12	2022-12
REVENUE	$1.6B	$1.6B	$1.5B	$1.6B
OPERATING INCOME	$-493.4M	$28.4M	$111.5M	$238.9M
NET INCOME	$-516.8M	$-6.9M	$67.7M	$180.6M
EPS (DILUTED)	-6.74	-0.09	0.84	2.16
OPERATING CASH FLOW	$50.4M	$129.4M	$140.0M	$264.5M
CASH	$235.0M	$246.4M	$276.4M	$456.7M
LONG-TERM DEBT	$726.6M	$760.5M	$775.0M	$775.0M
BUYBACKS	$221.0K	$52.5M	$275.0M	$125.0M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE